Wolfgang Lamm, Hannes Kaufmann, Markus Raderer, Martha Hoffmann, Andreas Chott, Christoph Zielinski and Johannes Drach (2011) “Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma”, Haematologica. Pavia, Italy, 96(7), pp. 1008-1014. doi: 10.3324/haematol.2011.041392.